Digital Library
Close Browse articles from a journal
 
Search for with title:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             56 results found
no title author magazine year volume issue page(s) type
1 Abstract Presenters 2011
 78 S1 p. x-
1 p.
 article
2 Abstracts 2011
 78 S1 p. viii-
1 p.
 article
3 Acknowledgements 2011
 78 S1 p. viii-
1 p.
 article
4 7 Adjuvant and neoadjuvant treatment in renal cell carcinoma (RCC) Bex, A.
 2011
 78 S1 p. S6-
1 p.
 article
5 10 Androgens and proinflammatory cytokines in development and progression of prostate cancer Culig, Z.
 2011
 78 S1 p. S7-
1 p.
 article
6 40 Atypical initial clinical presentation of a prostate cancer with normal PSA Tsoukalas, N.
 2011
 78 S1 p. S27-
1 p.
 article
7 Author index 2011
 78 S1 p. S31-
1 p.
 article
8 28 Choosing the extent of the lymph node dissection in surgical treatment of the bladder cancer with regional metastasis Ergashev, O.
 2011
 78 S1 p. S22-
1 p.
 article
9 CME accreditation and certificates 2011
 78 S1 p. viii-
1 p.
 article
10 17 Combining radiotherapy and new drugs in locally advanced prostate cancer Supiot, S.
 2011
 78 S1 p. S15-S16
2 p.
 article
11 32 Current status of prostate cancer in Lagos, Nigeria Adetayo, O.
 2011
 78 S1 p. S24-
1 p.
 article
12 38 Cytoreductive nephrectomy in advanced or metastatic renal cell carcinoma (mRCC): In the era of targeted strategies Toutziaris, C.
 2011
 78 S1 p. S26-
1 p.
 article
13 36 Dural metastases from prostatic adenocarcinoma: Case report and review of literature Salem, A.
 2011
 78 S1 p. S25-S26
2 p.
 article
14 ECCLU 2011 Invited Speakers' Disclosures 2011
 78 S1 p. S29-
1 p.
 article
15 Editorial Board 2011
 78 S1 p. ii-
1 p.
 article
16 ESO from A to Z 2011
 78 S1 p. S33-S42
10 p.
 article
17 18 Europa Uomo: The patients' voice Denis, L.
 2011
 78 S1 p. S16-
1 p.
 article
18 31 Evaluating the antitumour activity of docetaxel following treatment with abiraterone acetate and steroids: Evidence for cross-resistance Mezynski, J.
 2011
 78 S1 p. S23-S24
2 p.
 article
19 25 Ex-vivo ultrasound control of resection margins during partial nephrectomy Cerantola, Y.
 2011
 78 S1 p. S21-
1 p.
 article
20 Faculty 2011
 78 S1 p. ix-
1 p.
 article
21 6 First and further lines of therapy in clear cell renal cell carcinoma Rini, B.I.
 2011
 78 S1 p. S5-
1 p.
 article
22 14 High-intensity focused ultrasound and cryotherapy Murat, F.J.
 2011
 78 S1 p. S11-
1 p.
 article
23 Hotel accommodation 2011
 78 S1 p. vii-
1 p.
 article
24 20 Improving outcome from advanced prostate cancer through rational drug development de Bono, J.S.
 2011
 78 S1 p. S17-
1 p.
 article
25 35 Intermittent hormonal therapy in the treatment of prostate cancer Rahimov, N.
 2011
 78 S1 p. S25-
1 p.
 article
26 8 Kidney cancer: surgery including nephron-sparing surgery Van Poppel, H.
 2011
 78 S1 p. S6-
1 p.
 article
27 2 Localised invasive bladder cancer: Surgery Thalmann, G.N.
 2011
 78 S1 p. S3-
1 p.
 article
28 41 Localized invasive bladder cancer: neo-adjuvant chemotherapy? Bellmunt, J.
 2011
 78 S1 p. S1-S3
3 p.
 article
29 16 Locally advanced prostate cancer: Pro-radiation Parker, C.
 2011
 78 S1 p. S14-S15
2 p.
 article
30 5 Mechanisms of action in modern RCC treatment Rothermundt, C.
 2011
 78 S1 p. S4-S5
2 p.
 article
31 1 Mortality from urological cancers in Europe, 1970–2008 Bosetti, C.
 2011
 78 S1 p. S1-
1 p.
 article
32 37 Multiple successive surgery and chemotherapy helped to dramatically prolong life in patient with bladder cancer Shakhnovich, E.
 2011
 78 S1 p. S26-
1 p.
 article
33 9 New developments in the systemic treatment of advanced prostate cancer Tannock, I.F.
 2011
 78 S1 p. S7-
1 p.
 article
34 29 On the role of magnetic resonance imaging with Endorectal Coil (ER-MRI) in changing the stage (and treatment approach) in patients with early prostate cancer undergoing primary radiation Romano, M.
 2011
 78 S1 p. S22-S23
2 p.
 article
35 Organising secretariat 2011
 78 S1 p. vii-
1 p.
 article
36 Programme 2011
 78 S1 p. xi-xiv
nvt p.
 article
37 19 Prostate cancer: Management of pelvic nodes. Surgical perspective Van Poppel, H.
 2011
 78 S1 p. S16-S17
2 p.
 article
38 11 Prostate cancer: predicting life expectancy Terret, C.
 2011
 78 S1 p. S8-
1 p.
 article
39 33 Pure red cell dysplasia in a patient with metastatic cancer prostate Malek, R. Abdel
 2011
 78 S1 p. S24-
1 p.
 article
40 27 Quality of life in metastatic renal cell carcinoma patients with ECOG PS >2 receiving targeted therapy Tsimafeyeu, I.
 2011
 78 S1 p. S22-
1 p.
 article
41 12 Radical prostatectomy Ficarra, V.
 2011
 78 S1 p. S8-S9
2 p.
 article
42 26 Reasonability of lymph dissection in localized types of renal cell carcinoma Rahimov, N.
 2011
 78 S1 p. S21-
1 p.
 article
43 34 Role of immunehistochemical markers in definition of hormone sensation prostate cancer Kolesnikova, E.
 2011
 78 S1 p. S24-S25
2 p.
 article
44 15 Role of radical prostatectomy in locally advanced prostate cancer Heidenreich, A.
 2011
 78 S1 p. S11-S14
4 p.
 article
45 24 Role of surgery in the management of testis cancer Heidenreich, A.
 2011
 78 S1 p. S19-S20
2 p.
 article
46 Sharing Progress in Cancer Care 2011
 78 S1 p. viii-
1 p.
 article
47 22 Side effects of anti-androgen therapy Tombal, B.
 2011
 78 S1 p. S18-
1 p.
 article
48 21 SIOG (International Society of Geriatric Oncology) guidelines for the management of prostate cancer in senior adults Terret, C.
 2011
 78 S1 p. S17-S18
2 p.
 article
49 23 Stage 1 testicular germ cell cancers Horwich, A.
 2011
 78 S1 p. S18-S19
2 p.
 article
50 39 Supraclavicular lymphadenopathy as the initial clinical symptom of a rare histological type of renal cancer Tsoukalas, N.
 2011
 78 S1 p. S27-
1 p.
 article
51 3 The role of radiotherapy in muscle invasive bladder cancer James, N.
 2011
 78 S1 p. S3-
1 p.
 article
52 13 The truth on permanent prostate brachytherapy Battermann, J.J.
 2011
 78 S1 p. S9-S11
3 p.
 article
53 4 Treating bladder cancer: first-line, second-line, platinum-unfit DeSantis, M.
 2011
 78 S1 p. S3-S4
2 p.
 article
54 Venue 2011
 78 S1 p. vii-
1 p.
 article
55 30 Weight change analysis in advanced castration resistant prostate cancer (CRPC) patients treated with Abiraterone Acetate (AA) single agent and in combination with steroids Bianchini, D.
 2011
 78 S1 p. S23-
1 p.
 article
56 Welcome Berthold, Dominik
 2011
 78 S1 p. vii-
1 p.
 article
                             56 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands